S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Prologis Stock Leading U.S. Logistics Boom
Abbott Laboratories Outlook is Healthy: Buy the Dip

Lucy Scientific Discovery (LSDI) Competitors

$1.07
-0.03 (-2.75%)
(As of 05:45 PM ET)

LSDI vs. HSTO, SLRX, QLGN, INM, CMND, PTPI, ATNF, SNOA, PBLA, and ADIL

Should you be buying Lucy Scientific Discovery stock or one of its competitors? The main competitors of Lucy Scientific Discovery include Histogen (HSTO), Salarius Pharmaceuticals (SLRX), Qualigen Therapeutics (QLGN), InMed Pharmaceuticals (INM), Clearmind Medicine (CMND), Petros Pharmaceuticals (PTPI), 180 Life Sciences (ATNF), Sonoma Pharmaceuticals (SNOA), Panbela Therapeutics (PBLA), and Adial Pharmaceuticals (ADIL). These companies are all part of the "pharmaceutical preparations" industry.

Lucy Scientific Discovery vs.

Histogen (NASDAQ:HSTO) and Lucy Scientific Discovery (NASDAQ:LSDI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, community ranking, institutional ownership and risk.

Histogen has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500. Comparatively, Lucy Scientific Discovery has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500.

Lucy Scientific Discovery has a net margin of 0.00% compared to Lucy Scientific Discovery's net margin of -65,142.11%. Lucy Scientific Discovery's return on equity of -136.13% beat Histogen's return on equity.

Company Net Margins Return on Equity Return on Assets
Histogen-65,142.11% -136.13% -90.87%
Lucy Scientific Discovery N/A -294.74%-137.65%

Histogen received 6 more outperform votes than Lucy Scientific Discovery when rated by MarketBeat users. However, 100.00% of users gave Lucy Scientific Discovery an outperform vote while only 58.33% of users gave Histogen an outperform vote.

CompanyUnderperformOutperform
HistogenOutperform Votes
7
58.33%
Underperform Votes
5
41.67%
Lucy Scientific DiscoveryOutperform Votes
1
100.00%
Underperform Votes
No Votes

72.6% of Lucy Scientific Discovery shares are held by institutional investors. 3.3% of Histogen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Histogen
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Lucy Scientific Discovery
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Lucy Scientific Discovery has lower revenue, but higher earnings than Histogen. Histogen is trading at a lower price-to-earnings ratio than Lucy Scientific Discovery, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Histogen$3.77M0.57-$10.62M-$2.81-0.18
Lucy Scientific Discovery$10K188.27-$8.99M-$7.00-0.15

In the previous week, Lucy Scientific Discovery's average media sentiment score of 0.00 beat Histogen's score of -1.00 indicating that Histogen is being referred to more favorably in the media.

Company Overall Sentiment
Histogen Neutral
Lucy Scientific Discovery Negative

Summary

Histogen beats Lucy Scientific Discovery on 8 of the 15 factors compared between the two stocks.

Get Lucy Scientific Discovery News Delivered to You Automatically

Sign up to receive the latest news and ratings for LSDI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LSDI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LSDI vs. The Competition

MetricLucy Scientific DiscoveryPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.88M$6.58B$4.73B$7.40B
Dividend YieldN/A3.12%5.40%3.96%
P/E Ratio-0.1511.59225.1116.45
Price / Sales188.27280.002,430.1587.62
Price / CashN/A29.6947.4735.32
Price / Book0.375.384.604.20
Net Income-$8.99M$149.48M$101.21M$211.63M
7 Day Performance-13.03%-6.36%-4.63%-4.38%
1 Month Performance-18.96%-6.30%-4.32%-3.41%
1 Year Performance-88.60%-4.35%10.56%4.57%

Lucy Scientific Discovery Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HSTO
Histogen
0 of 5 stars
$0.50
flat
N/A-52.4%$2.14M$3.77M-0.187
SLRX
Salarius Pharmaceuticals
0 of 5 stars
$0.48
+2.1%
N/A-70.9%$2.07M$1.84M-0.112Gap Down
QLGN
Qualigen Therapeutics
0.1116 of 5 stars
$0.40
+5.3%
N/A-68.4%$2.07M$4.98M0.0031News Coverage
Gap Up
INM
InMed Pharmaceuticals
0 of 5 stars
$0.34
+3.0%
N/A-75.6%$2.06M$4.14M0.0013News Coverage
Gap Down
CMND
Clearmind Medicine
0 of 5 stars
$1.32
+17.9%
N/A-93.2%$2.24MN/A0.00N/ANews Coverage
PTPI
Petros Pharmaceuticals
1.8745 of 5 stars
$0.91
-2.1%
$4.00
+339.1%
-84.6%$2.00M$5.82M-0.1424News Coverage
ATNF
180 Life Sciences
0 of 5 stars
$2.32
flat
N/A-93.7%$1.97MN/A0.005Positive News
SNOA
Sonoma Pharmaceuticals
3.0728 of 5 stars
$0.15
+7.0%
$3.25
+2,027.0%
-82.9%$2.39M$13.27M-0.169Gap Up
PBLA
Panbela Therapeutics
1.2912 of 5 stars
$0.54
-1.8%
$500.00
+92,561.2%
-99.8%$1.88MN/A0.006News Coverage
Positive News
Gap Up
ADIL
Adial Pharmaceuticals
0.7871 of 5 stars
$1.13
flat
N/A-69.9%$1.88MN/A-0.2016

Related Companies and Tools

This page (NASDAQ:LSDI) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners